First patient randomised in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-G3031 Read more
NovaLead Pharma commences Phase 3 Clinical Trial of Its Novel Topical Drug Galnobax for DFU Read more
‘Our TUXEDO study clearly suggests that the new generation everolimus stents are best in terms of efficacy and safety’ Read more